Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,685
Closed -$294K – 154
2021
Q4
$294K Buy
1,685
+279
+20% +$46.5K 0.07% 72
2021
Q3
$233K Buy
1,406
+1,306
+1,306% +$225K 0.07% 79
2021
Q2
$18K Buy
+100
New +$18.3K 0.01% 198
2020
Q4
– Sell
-100
Closed -$21K – 52
2020
Q3
$21K Buy
+100
New +$22.3K 0.01% 162

Other funds holding CLX

Beck Bode LLC's CLX Position: Q1 2022 in Review

Beck Bode LLC sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,685 shares — an estimated $294K sold.

Beck Bode LLC first reported a position in CLX in Q3 2020 and held it in 4 quarters. The position peaked at $294K in Q4 2021. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Beck Bode LLC reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Beck Bode LLC sold 1,685 Clorox shares in Q1 2022, an estimated $294K.
  • Beck Bode LLC first reported a position in Clorox in Q3 2020 and held it in 4 quarters.
  • Beck Bode LLC's Clorox position peaked at $294K in Q4 2021.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Beck Bode LLC's 13F filing for Q1 2022, filed 2 May 2022.